Is Gsk Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NYSE: GSK) stock is to Hold GSK stock.
Out of 2 analysts, 0 (0%) are recommending GSK as a Strong Buy, 0 (0%) are recommending GSK as a Buy, 2 (100%) are recommending GSK as a Hold, 0 (0%) are recommending GSK as a Sell, and 0 (0%) are recommending GSK as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year GSK price target, the average GSK price target is $55.90, with the highest GSK stock price forecast at $55.90 and the lowest GSK stock price forecast at $55.90.
The Wall Street analyst predicted that Gsk's share price could reach $55.90 by Oct 29, 2027. The average Gsk stock price prediction forecasts a potential upside of 14.83% from the current GSK share price of $48.68.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.